Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Frequent mutations in the MITF pathway in melanoma.

Cronin JC, Wunderlich J, Loftus SK, Prickett TD, Wei X, Ridd K, Vemula S, Burrell AS, Agrawal NS, Lin JC, Banister CE, Buckhaults P, Rosenberg SA, Bastian BC, Pavan WJ, Samuels Y.

Pigment Cell Melanoma Res. 2009 Aug;22(4):435-44. doi: 10.1111/j.1755-148X.2009.00578.x. Epub 2009 Apr 29.

2.

A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.

Lister JA, Capper A, Zeng Z, Mathers ME, Richardson J, Paranthaman K, Jackson IJ, Patton EE.

J Invest Dermatol. 2014 Jan;134(1):133-40. doi: 10.1038/jid.2013.293. Epub 2013 Jul 5.

3.
4.

Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10.

Verastegui C, Bille K, Ortonne JP, Ballotti R.

J Biol Chem. 2000 Oct 6;275(40):30757-60.

5.

MITF pathway mutations in melanoma.

Yokoyama S, Salma N, Fisher DE.

Pigment Cell Melanoma Res. 2009 Aug;22(4):376-7. doi: 10.1111/j.1755-148X.2009.00599.x. Epub 2009 Jun 25. No abstract available.

PMID:
19558635
6.

Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.

Fernández-Barral A, Orgaz JL, Baquero P, Ali Z, Moreno A, Tiana M, Gómez V, Riveiro-Falkenbach E, Cañadas C, Zazo S, Bertolotto C, Davidson I, Rodríguez-Peralto JL, Palmero I, Rojo F, Jensen LD, del Peso L, Jiménez B.

Neoplasia. 2014 Jun;16(6):529-42. doi: 10.1016/j.neo.2014.06.001. Epub 2014 Jul 13.

7.

Exome sequencing reveals the likely involvement of SOX10 in uveal melanoma.

Das D, Kaur I, Ali MJ, Biswas NK, Das S, Kumar S, Honavar SG, Maitra A, Chakrabarti S, Majumder PP.

Optom Vis Sci. 2014 Jul;91(7):e185-92. doi: 10.1097/OPX.0000000000000309.

PMID:
24927141
8.

The impact of MITF on melanoma development: news from bench and bedside.

Roider EM, Fisher DE.

J Invest Dermatol. 2014 Jan;134(1):16-7. doi: 10.1038/jid.2013.390.

9.

Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.

Clevenger J, Joseph C, Dawlett M, Guo M, Gong Y.

Cancer Cytopathol. 2014 Oct;122(10):779-85. doi: 10.1002/cncy.21458. Epub 2014 Jun 20.

10.

GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.

Javelaud D, Alexaki VI, Pierrat MJ, Hoek KS, Dennler S, Van Kempen L, Bertolotto C, Ballotti R, Saule S, Delmas V, Mauviel A.

Pigment Cell Melanoma Res. 2011 Oct;24(5):932-43. doi: 10.1111/j.1755-148X.2011.00893.x. Epub 2011 Aug 18.

PMID:
21801332
11.

Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.

Sensi M, Catani M, Castellano G, Nicolini G, Alciato F, Tragni G, De Santis G, Bersani I, Avanzi G, Tomassetti A, Canevari S, Anichini A.

J Invest Dermatol. 2011 Dec;131(12):2448-57. doi: 10.1038/jid.2011.218. Epub 2011 Jul 28.

PMID:
21796150
12.

Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.

Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D, Le Gras S, Cormont M, Ballotti R, Bertolotto C, Davidson I.

Oncogene. 2011 May 19;30(20):2319-32. doi: 10.1038/onc.2010.612. Epub 2011 Jan 24.

PMID:
21258399
13.

Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.

Anghel SI, Correa-Rocha R, Budinska E, Boligan KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem GE, Fisher DE, Lévy F, Delorenzi M, Piguet V.

Pigment Cell Melanoma Res. 2012 Jul;25(4):482-7. doi: 10.1111/j.1755-148X.2012.01018.x. Erratum in: Pigment Cell Melanoma Res. 2012 Nov;25(6):834. Correa-Rochal, Rafael [corrected to Correa-Rocha, Rafael]; Boliganl, Kayluz F [corrected to Boligan, Kayluz F].

PMID:
22594792
14.

ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.

Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, Goding CR, Galibert MD.

Pigment Cell Melanoma Res. 2010 Feb;23(1):93-102. doi: 10.1111/j.1755-148X.2009.00652.x. Epub 2009 Nov 6.

PMID:
19895547
15.

Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.

Reifenberger J, Knobbe CB, Sterzinger AA, Blaschke B, Schulte KW, Ruzicka T, Reifenberger G.

Int J Cancer. 2004 Apr 10;109(3):377-84.

16.

Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.

Wellbrock C, Rana S, Paterson H, Pickersgill H, Brummelkamp T, Marais R.

PLoS One. 2008 Jul 16;3(7):e2734. doi: 10.1371/journal.pone.0002734.

17.

Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.

Vachtenheim J, Novotná H.

Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):1075-82.

PMID:
10644012
18.

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.

Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C, Ballotti R.

Oncogene. 2012 May 10;31(19):2461-70. doi: 10.1038/onc.2011.425. Epub 2011 Sep 26.

PMID:
21996743
19.

A germline oncogenic MITF mutation and tumor susceptibility.

Paillerets BB, Lesueur F, Bertolotto C.

Eur J Cell Biol. 2014 Jan-Feb;93(1-2):71-5. doi: 10.1016/j.ejcb.2013.10.002. Epub 2013 Oct 26. Review.

PMID:
24290354
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk